The Library

The role of nitrogen oxides in human adaptation to hypoxia

Tools

University College, London. Centre for Altitude, Space and Extreme environment medicine. Caudwell Xtreme Everest Research Group (Including: Levett, Denny Z. H., Fernandez, Bernadette O., Riley, Heather L., Martin, Daniel S., Mitchell, Kay, Leckstrom, Carl A., Ince, C. (Can), Whipp, Brian J., Mythen, Monty, Montgomery, Hugh E., Grocott, Michael P. W. and Feelisch, Martin). (2011) The role of nitrogen oxides in human adaptation to hypoxia. Scientific Reports, Vol.1 (No.109). ISSN 2045-2322

Preview

Text
WRAP_Feelisch_srep00109.pdf - Published Version
Download (922Kb)

Official URL: http://dx.doi.org/10.1038/srep00109

Abstract

Lowland residents adapt to the reduced oxygen availability at high altitude through a process known as acclimatisation, but the molecular changes underpinning these functional alterations are not well understood. Using an integrated biochemical/whole-body physiology approach we here show that plasma biomarkers of NO production (nitrite, nitrate) and activity (cGMP) are elevated on acclimatisation to high altitude while S-nitrosothiols are initially consumed, suggesting multiple nitrogen oxides contribute to improve hypoxia tolerance by enhancing NO availability. Unexpectedly, oxygen cost of exercise and mechanical efficiency remain unchanged with ascent while microvascular blood flow correlates inversely with nitrite. Our results suggest that NO is an integral part of the human physiological response to hypoxia. These findings may be of relevance not only to healthy subjects exposed to high altitude but also to patients in whom oxygen availability is limited through disease affecting the heart, lung or vasculature, and to the field of developmental biology.

[error in script] [error in script]

Item Type:	Journal Article
Subjects:	Q Science > QP Physiology
Divisions:	Faculty of Medicine > Warwick Medical School > Metabolic and Vascular Health Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Acclimatization -- Physiology, Nitrogen oxides -- Physiological effect, Altitude, Influence of
Journal or Publication Title:	Scientific Reports
Publisher:	Nature Publishing Group
ISSN:	2045-2322
Date:	6 October 2011
Volume:	Vol.1
Number:	No.109
Identification Number:	10.1038/srep00109
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Open Access
Funder:	BOC Health Care, Eli Lilly and Company, London Clinic, Smiths Medical, Montres Rolex S.A., Association of Anaesthetists of Great Britain and Ireland (AAGBI), Intensive Care Society (Great Britain) (ICS), Halley Stewart Trust, Great Britain. Dept. of Health (DoH), Medical Research Council (Great Britain) (MRC)
References:	1. Penaloza, D. & Arias-Stella, J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation. 115, 1132–1146 (2007). 2. West, J. B., Schoene, R. B. &Milledge, J. S. High Altitude Medicine and Physiology (Hodder Arnold, London, 2007). 3. Calbet, J. A. et al. Why is VO2 max after altitude acclimatization still reduced despite normalization of arterial O2 content? Am J Physiol Regul Integr Comp Physiol. 284, R304–R316 (2003). 4. Grocott, M. P. et al. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med. 360, 140–149 (2009). 5. Beall, C. M. et al. Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci USA. 107, 11459–11464 (2010). 6. Yi, X. et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science. 329, 75–78 (2010). 7. Aragones, J. et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet. 40, 170–180 (2008). 8. Grocott, M., Montgomery, H. & Vercueil, A. High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit Care. 11, 203 (2007). 9. Levett, D. Z. et al. Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia. BMC Med Res Methodol. 10, 98 (2010). 10. Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43, 109–142 (1991). 11. Wink, D. A. et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal. 3, 203–213 (2001). 12. Jobgen,W. S., Fried, S. K., Fu, W. J., Meininger, C. J. &Wu, G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 17, 571–588 (2006). 13. Taylor, C. T. & Moncada, S. Nitric oxide, cytochrome c oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol. 30, 643–647 (2010). 14. Dosek, A., Ohno, H., Acs, Z., Taylor, A. W. & Radak, Z. High altitude and oxidative stress. Respir Physiol Neurobiol. 158, 128–131 (2007). 15. Bru¨ne, B. & Zhou, J. Hypoxia-inducible factor-1alpha under the control of nitric oxide. Methods Enzymol. 435, 463–478 (2007). 16. Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 7, 156–167 (2008). 17. Feelisch, M. et al. Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems. J Biol Chem. 283, 33927–33934 (2008). 18. Erzurum, S. C. et al. Higher blood flow and circulating NO products offset highaltitude hypoxia among Tibetans. Proc Natl Acad Sci USA. 104, 17593–17598 (2007). 19. Martin, D. S. et al. Changes in sublingual microcirculatory flow index and vessel density on ascent to altitude. Exp Physiol. 95, 880–891 (2010). 20. Bailey, S. J. et al. Dietary nitrate supplementation reduces the O2 cost of lowintensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 107, 1144–1155 (2009). 21. Larsen, F. J. et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab. 13, 149–159 (2011). 22. Moncada, S., Palmer, R. M. & Gryglewski, R. J. Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 83, 9164–9168 (1986). 23. Marconi, C. Economy of locomotion in high-altitude Tibetan migrants exposed to normoxia. J Physiol. 569, 667–675 (2005). 24. Spoto, G., Di Giulio, C., Contento, A. &Di Stilio, M. Hypoxic and hyperoxic effect on blood phosphodiesterase activity in young and old rats. Life Sci. 63, PL349– PL353 (1998). 25. Butler, A. R. & Feelisch, M. Therapeutic uses of inorganic nitrite and nitrate: From the past to the future. Circulation. 117, 2151–2159 (2008). 26. Cosby, K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 9, 1498–1505 (2003). 27. Lauer, T. et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA. 98, 12814–12819 (2001). 28. Bryan,N. S. et al.Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol. 1, 290–297 (2005). 29. Reichert, E. T. & Mitchell, S. W. On the physiological action of potassium nitrite. Am J Med Sci. 156, 158–180 (1880). 30. Trzeciak, S. et al. Microcirculatory Alterations in Resuscitation and Shock Investigators. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med. 49, 88–98 (2007). 31. Lipton, A. J. et al. S-nitrosothiols signal the ventilatory response to hypoxia. Nature. 413, 171–174 (2001). 32. Sumbayev, V. V., Budde, A., Sumbayev, V. V., Budde, A., Zhou, J. & Bru¨ne, B. HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett. 535, 106–112 (2003). 33. Lima, B., Forrester, M. T., Hess, D. T. & Stamler, J. S. S-nitrosylation in cardiovascular signaling. Circ Res. 106, 633–646 (2010). 34. Thomas, D. D. et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med. 45, 18–31 (2008). 35. Martin, D. S., Khosravi, M., Grocott, M. P. &Mythen, M. G. Concepts in hypoxia reborn. Crit Care. 14, 315 (2010). 36. Hayes, M. A. et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 330, 1717–1722 (1994). 37. Gattinoni, L. et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 333, 1025–1032 (1995). 38. Lopez, A. et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med. 32, 21–30 (2004). 39. Whipp, B. J., Ward, S. A. &Wasserman, K. Respiratory markers of the anaerobic threshold. Adv Cardiol. 35, 47–64 (1986). 40. Beaver, W. L., Wasserman, K. & Whipp, B. J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 60, 2020–2027 (1986). 41. Hansen, J. E., Sue, D. Y. & Wasserman, K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 129, S49–S55 (1984). 42. Whipp, B. J., Davis, J. A., Torres, F. & Wasserman, K. A test to determine parameters of aerobic function during exercise. J Appl Physiol. 50, 217–221 (1981). 43. Huszczuk,A., Whipp, B. J.&Wasserman, K.Arespiratory gas exchange simulator for routine calibration in metabolic studies. Eur Respir J. 3, 465–468 (1990). 44. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Resp Crit Care Med. 167, 211–277 (2003). 45. De Backer, D. et al. How to evaluate the microcirculation: report of a round table conference. Crit Care. 11, R101 (2007). 46. Rassaf, T., Bryan, N. S., Kelm, M. & Feelisch, M. Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med. 33, 1590–1596 (2002).
URI:	http://wrap.warwick.ac.uk/id/eprint/40856